|
TWN Info Service on Intellectual Property Issues (2020)
- TWN Briefing Paper on Access and benefit sharing for pathogens: An overview of the issues at the WHO (2021)
by Edward Hammond (21 Dec 20)
- EU-led initiative on trade and health suffers major setback
by D. Ravi Kanth (21 Dec 20)
- COVID-19: "Big Pharma is Fooling Us"
by Stephen Buranyi (18 Dec 20)
- COVID-19: A vaccine that was hijacked by the rich
by IPS/Thalif Deen (14 Dec 20)
- TRIPS waiver gains more support despite efforts to stall its passage
by D. Ravi Kanth (14 Dec 20)
- Want Vaccines Fast? Suspend Intellectual Property Rights
by Achal Prabhala, Arjun Jayadev & Dean Baker (10 Dec 20)
- New TWN Briefing Paper on TRIPS Waiver Proposal
by Biswajit Dhar & K.M. Gopakumar (09 Dec 20)
- US & allies adopt "diversionary" tactics to block TRIPS waiver
by D. Ravi Kanth (08 Dec 20)
- Public services international supports waiver
by Kanaga Raja (06 Dec 20)
- COVID-19: Compilation of TRIPS Waiver Proposal materials
(02 Dec 20)
- WTO members should ensure access to affordable medicines
(01 Dec 20)
- Almost 100 UK parliamentarians urge UK government to support TRIPS waiver
(30 Nov 20)
- Amnesty International Calls on WTO Members to Strongly Support TRIPS Waiver Proposal
(26 Nov 20)
- Developed countries continue to block TRIPS waiver proposal
by D. Ravi Kanth (24 Nov 20)
- Waiving Intellectual Property Rules Key to Beating Covid-19
by Aruna Kashyap & Margaret Wurth (18 Nov 20)
- The Covid vaccine will benefit humanity – we should all own the patent
by Owen Jones (17 Nov 20)
- TRIPS Council to resume discussions next week on TRIPS waiver
by D. Ravi Kanth (16 Nov 20)
- COVID-19: Licensing deals on vaccines reinforce need for TRIPS waiver
by D. Ravi Kanth (12 Nov 20)
- Rights: UN experts criticize countries for hoarding COVID-19 vaccines
by Kanaga Raja (11 Nov 20)
- UN HR Experts Welcomes Waiver
(10 Nov 20)
- Battle-lines being drawn over upcoming discussion on TRIPS waiver
by D. Ravi Kanth (07 Nov 20)
- LDCs call for extension of transition period to implement TRIPS
by D. Ravi Kanth (22 Oct 20)
- South Africa, India strongly rebut arguments against TRIPS waiver
by D. Ravi Kanth (20 Oct 20)
- Proposal for TRIPS waiver secures strong support from South
by D. Ravi Kanth (20 Oct 20)
- Safeguarding the World's Response to COVID-19 from the Intellectual Property Police
by Biswajit Dhar & K.M. Gopakumar (19 Oct 20)
- CSOs call for strong support for TRIPS waiver to combat COVID-19
by Kanaga Raja (16 Oct 20)
- PHM Call to Action on TRIPS Waiver Proposal
(15 Oct 20)
- COVID-19: CSO letter supporting TRIPS Waiver Proposal
(15 Oct 20)
- Attempts to undermine talks on TRIPS waiver to combat COVID-19?
by D. Ravi Kanth (14 Oct 20)
- Intellectual Property & Covid 19
(12 Oct 20)
- India, South Africa seek TRIPS waiver to combat COVID-19
by D. Ravi Kanth (06 Oct 20)
- PHM/TWN Webinar on Intellectual Property Implications for Access to Covid19 Medical Products
(06 Oct 20)
- Launch of Spotlight on Sustainable Development 2020 report
(18 Sept 20)
- COVID-19: WHO suffers setback on its plan for global vaccine access facility
by D. Ravi Kanth (03 Sept 20)
- Finding Traditional Knowledge’s Place in the Digital Sequence Information Debate (Spanish and French)
by Edward Hammond (02 Sept 20)
- COVID-19: South Africa, India call for enabling technology transfer in TRIPS
by D. Ravi Kanth (11 Aug 20)
- South voices concerns over "vaccine nationalism" amid COVID-19
by D. Ravi Kanth (10 Aug 20)
- COVID-19: Publicly-funded Vanderbilt University aims for vaccine financial windfall
by Edward Hammond (07 Aug 20)
- COVID-19: South Africa calls for "holistic" approach to TRIPS flexibilities
by D. Ravi Kanth (04 Aug 20)
- COVID-19: Patent dispute looms as a major complication for Moderna’s vaccine
by Edward Hammond (03 Aug 20)
- Intellectual property dispute deepens, leaving Inovio's COVID-19 candidate in limbo
(16 Jul 20)
- Finding Traditional Knowledge’s Place in the Digital Sequence Information Debate
(15 Jul 20)
- COVID-19: Are we being misled again by Big Pharma?
by Heba Wanis (10 Jul 20)
- COVID-19: Questions over WHO’s Global Equitable Allocation Framework & its workings
by Sangeeta Shashikant & K.M. Gopakumar (06 Jul 20)
- COVID-19: Global Concern that Gavi's Vaccine Initiative Promotes Inequitable Access
by Sangeeta Shashikant (29 Jun 20)
- COVID-19: South concerned over TRIPS barrier to access affordable vaccines
by D. Ravi Kanth (26 Jun 20)
- COVID-19 vaccines: EU prioritises preferential access, paying lip-service to global solidarity
by Sangeeta Shashikant & K.M. Gopakumar (26 Jun 20)
- Intellectual property lawsuit holds back production of COVID-19 vaccine candidate
by Edward Hammond (19 Jun 20)
- TWN Briefing paper on 'International negotiations by virtual means in the time of the Covid-19 pandemic'
(05 Jun 20)
- WHO: Member States reject US tirade against WHO
by TWN (26 May 20)
- WHO: Health Assembly adopts resolution on the global response to COVID-19
by Kanaga Raja (26 May 20)
- COVID-19: CSOs, observers push for access to medical products at WHA
by TWN (22 May 20)
- WHO: Leaders call COVID-19 vaccines a "global public good"
by TWN (20 May 20)
- COVID-19: Civil Society Letter to UNITAID, the World Health Organization (WHO) and Member States
(18 May 20)
- CSO call for revocation of patents on remdesivir in India
(15 May 20)
- WHO: Chair's COVID-19 text builds on "Business as Usual" approaches, sidelining Member States
by TWN (11 May 20)
- COVID-19: Pledges of 7.4 billion euro raise several ambiguities
by K M Gopakumar & Chee Yoke Ling (11 May 20)
- COVID-19: Announcing VAXMAP - interactive world map on vaccine development and production
(07 May 20)
- WHO: EU draft for WHA on "COVID-19 Response" lacks clarity
by TWN (05 May 20)
- COVID-19: CSOs call for fair & equitable benefit sharing of medical products
by Kanaga Raja (28 Apr 20)
- COVID-19: Is WHO's ACT Accelerator old wine in a new bottle?
by K. M. Gopakumar (28 Apr 20)
- WHO: Launches initiative for equitable access to COVID-19 tools
by Edward Hammond (28 Apr 20)
- WHO: Where is fair and equitable benefit sharing of medical products?
by Sangeeta Shashikant & Edward Hammond (24 Apr 20)
- UN Monitor: COVID-19 & UN Silence Procedure
(23 Apr 20)
- COVID-19: From bats to another mammal to humans, now deadly pandemic
by Chakravarthi Raghavan (22 Apr 20)
- India's HCQ Export: Will the US Reciprocate with Remdesivir?
by K.M. Gopakumar (16 Apr 20)
- WHO DG condemns "racist" remarks on testing COVID-19 vaccines in Africa; raises patent-related initiatives
by D. Ravi Kanth (09 Apr 20)
- COVID-19 exposes fragile world order, thin veneer of civilization
by Chakravarthi Raghavan (08 Apr 20)
- Drugs That Could Be Used to Beat COVID-19 Have Another Barrier - Patents
by K.M. Gopakumar & Prathibha Sivasubramaniam (02 Apr 20)
- New COVID-19 Rapid Diagnostic Approved On 'GeneXpert' TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries
by Elaine Ruth Fletcher & Svet Lustig (25 Mar 20)
- We Need Strong Public Health Care to Contain the Global Corona Pandemic
by Wim De Ceukelaire & Chiara Bodini (25 Mar 20)
- AbbVie Drops Patent Rights for Kaletra Antiviral Treatment
(24 Mar 20)
- Countries Prepare for Compulsory License to Deal with Covid-19 Pandemic
(23 Mar 20)
- Trump's attempt to buy a coronavirus vaccine shows why big pharma needs to change
by Diarmaid McDonald (17 Mar 20)
- Big Pharma May Pose an Obstacle to Vaccine Development
by Gerald Posner (17 Mar 20)
- Intellectual property raises costs of living
by IPS/Claire Lim & Jomo Kwame Sundaram (28 Feb 20)
- Can a US-India Trade Deal Permanently Alter the Way Indians Access Medicines?
(25 Feb 20)
- Indian MP urges Prime Minister to act on compulsory licence for TB medicines production
(17 Feb 20)
- Find the Missing Millions: Malaysia’s experience with nationwide hepatitis C screening campaign in the general population
(13 Feb 20)
- CSO concerns on India's IP laws, access to medical devices and US-India FTA
(10 Feb 20)
- WHO Secretariat documents silent on patent barriers to scale up drug resistant TB treatment
(05 Feb 20)
BACK TO
MAIN | ONLINE BOOKSTORE
| HOW TO ORDER
|
